Article
[Response criteria for enzyme substitution in Gaucher disease].
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde - 1 Oct 1992
Berthold F, Sieverts H, Benz-Bohm G, Landwehr P, Harzer K
Abstract excerpt
Recently the intravenous enzyme replacement therapy with modified beta-glucocerebrosidase has become available for patients with M. Gaucher. We report here the considerable improvement of activity and vigor in a 5 year old girl with type 1 M. Gaucher administering 60 IU/kg every two weeks for 6 months. The platelet count increased from 82-96/nl to more than 150/nl and hemoglobin from 10.8 to more than 12 g/dl....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
